A representative image of MM120 ODT, a pharmaceutically optimized form of LSD developed by New York-based MindMed being studied for the treatment of generalized anxiety disorder.
Courtesy of Catalen… [+8350 chars]
Could LSD be the key to easing anxiety? UCSF researchers are testing it - San Francisco Chronicle
UCSF is recruiting for MindMed’s phase 3 LSD trial for generalized anxiety disorder, after early results showed symptom relief lasting up to 3 months.
By:Erin Allday
Source:San Francisco Chronicle
Published:
Related News
S&P 500 Futures Advance, Japanese Bonds Rebound: Markets Wrap - Bloomberg.com
Japanese bonds rebounded after a selloff that rippled through global debt markets, while US equity-index futures rose as volatility showed tentative signs of easing.
Bloomberg•Anand Krishnamoorthy
Sony to Cede Control of Bravia TVs to China’s TCL Electronics - Bloomberg.com
Sony Group Corp. is spinning off control of its home entertainment business, including the flagship Bravia television brand, to Chinese rival TCL Electronics Holdings Ltd., the latest Japanese company to cut exposure in the low-margin segment.
Bloomberg•Mayumi Negishi
Warren Buffett's successor eyes selling off Berkshire Hathaway's 325 million Kraft Heinz shares - AP News
Warren Buffett’s successor appears to be considering his first significant move after taking over as CEO this month. Kraft Heinz warned investors Tuesday that Berkshire Hathaway may be interested in selling its 325 million shares in the name brand food giant …
Associated Press•Josh Funk